Question

Difficulty: MediumInfectious Diseases

A 71-year-old man is evaluated on the medical ward on hospital day 3. He was initially admitted for severe community-acquired pneumonia presenting with fever, productive cough, hypoxemia, and a dense left lower lobe consolidation on a chest radiograph. At the time of admission, empiric therapy with intravenous ceftriaxone and oral azithromycin was initiated. He has shown excellent clinical improvement; his oxygen requirements have resolved, and he has been afebrile for the past 24 hours. The patient is currently tolerating a regular diet and ambulating in the hallways. Both blood and high-quality sputum cultures obtained on admission have finalized, demonstrating the growth of *Streptococcus pneumoniae*. Susceptibility testing results for the isolate are as follows:

Antimicrobial AgentInterpretationMinimum Inhibitory Concentration (MIC)
PenicillinSusceptible0.030.03 µg/mL
AmoxicillinSusceptible≤1.0\le 1.0 µg/mL
CeftriaxoneSusceptible0.250.25 µg/mL
LevofloxacinSusceptible0.50.5 µg/mL
AzithromycinResistant>8.0> 8.0 µg/mL

The patient is being prepared for discharge with a prescription to complete a 7-day total course of antibiotics. Which of the following is the most appropriate antibiotic regimen for this patient's discharge?

  1. Oral amoxicillinAnswer
  2. B
    Oral amoxicillin-clavulanate
  3. C
    Oral levofloxacin
  4. D
    Oral cefpodoxime
  5. E
    Intravenous ceftriaxone via a peripherally inserted central catheter

Answer

Oral amoxicillin
The correct response identifies that the patient requires de-escalation of his antibiotic regimen. He initially received standard empiric therapy (ceftriaxone and azithromycin) for inpatient community-acquired pneumonia. With the pathogen identified as a penicillin-susceptible strain of *Streptococcus pneumoniae*, and the patient clinically stable and tolerating oral intake, the most appropriate next step is to transition to a narrow-spectrum oral agent. High-dose oral amoxicillin effectively treats this infection while strictly adhering to antimicrobial stewardship principles.

Step-by-Step Solution

1
Identify the primary pathogen and analyze its susceptibility profile from the provided laboratory data.
The pathogen is Streptococcus pneumoniae, which is susceptible to penicillin (and amoxicillin), ceftriaxone, and levofloxacin, but resistant to azithromycin.
Determining the specific etiology and resistance pattern is required to tailor ongoing antimicrobial therapy away from empiric regimens.
2
Evaluate the patient's clinical trajectory to determine the appropriate route of administration (intravenous vs. oral).
The patient is clinically improved, afebrile, hemodynamically stable, and tolerating an oral diet, indicating he is ready for transition to oral therapy.
Early transition from intravenous to oral therapy reduces catheter-related complications, shortens hospital length of stay, and decreases healthcare costs.
3
Select the most appropriate oral agent based on the principles of antimicrobial stewardship.
Oral amoxicillin is the optimal choice because it provides highly effective, targeted, narrow-spectrum coverage against this specific isolate.
Using the narrowest effective spectrum minimizes collateral damage to the host microbiome and reduces the selection pressure that drives antimicrobial resistance.

Key Concept

De-escalation of empiric broad-spectrum antibiotic therapy to a targeted, narrow-spectrum agent (e.g., oral amoxicillin) is the standard of care for clinically stable patients with penicillin-susceptible Streptococcus pneumoniae pneumonia.
Estimated Time:1m 0s
Rate this question